Jupiter Life Line Hospitals Ltd vs Maestros Electronics Telecommun Systems Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Jupiter Life Line Hospitals Ltd is ₹ 244.25 as of 23 Oct 15:30 . The P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Maestros Electronics & Telecommun. Systems Ltd changed from 12.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 years The Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 60.31 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 years The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The revenue of Maestros Electronics & Telecommun. Systems Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 10.61 crore. This represent the decline of -100% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The ebitda of Maestros Electronics & Telecommun. Systems Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 2.4 crore. This represent the decline of -100% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The net profit of Maestros Electronics & Telecommun. Systems Ltd changed from ₹ 1.25 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 yearsThe Dividend Payout of Maestros Electronics & Telecommun. Systems Ltd changed from 22.04 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the 'Jupiter' brand.
The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds.
The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare.

About Maestros Electronics & Telecommun. Systems Ltd

Maestros Electronics & Telecommunications Systems Limited was incorporated on February 19, 2010.
At present, Company is engaged in activities pertaining to design, development, and manufacturing of creating products and services for financial inclusion, cardiology, gynecology, critical care patient and diseases management in medicine with rich experience in latest technologies and communication. It provide an advanced portfolio of products and services, including patient monitors, electrocardiographs, defibrillators, pulse oximeters, fetal monitors, stress test systems and much more. With state-of-the-art R&D and manufacturing facilities located in Mumbai, India, Company excel in creating cutting-edge solutions tailored to the needs of clients.
It mainly operates into two segments viz, Electronics & Instrumentation (E&T) and Telemedicine.

FAQs for the comparison of Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd

Which company has a larger market capitalization, Jupiter Life Line Hospitals Ltd or Maestros Electronics & Telecommun. Systems Ltd?

Market cap of Jupiter Life Line Hospitals Ltd is 8,007 Cr while Market cap of Maestros Electronics & Telecommun. Systems Ltd is 85 Cr

What are the key factors driving the stock performance of Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd?

The stock performance of Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd?

As of October 25, 2026, the Jupiter Life Line Hospitals Ltd stock price is INR ₹244.25. On the other hand, Maestros Electronics & Telecommun. Systems Ltd stock price is INR ₹77.7.

How do dividend payouts of Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd compare?

To compare the dividend payouts of Jupiter Life Line Hospitals Ltd and Maestros Electronics & Telecommun. Systems Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.